Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2022-06-08 00:00:00 ET · period of report 2022-06-07 · accession 0001209191-22-034996 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-08 | 2022-06-07 | FATE | Agarwal Shefali | Dir | S - Sale | $21.89 | -841 | 1,840 | -31% | -$18.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-07 | S | D | 841 | $21.89 | 1,840 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $21.61 to $22.19 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2. |